Affera
Affera makes cardiac mapping, navigation, and catheter-based ablation technologies for treating cardiac arrhythmias.
- Acquired, subsidiary of Medtronic
- Newton, MA, USUnited States
Affera makes cardiac mapping, navigation, and catheter-based ablation technologies for treating cardiac arrhythmias.
affera.comCrawled Oct 25, 2026
Affera is developing a comprehensive integrated platform to efficiently deliver durable therapy for a broad set of cardiac arrhythmia patients.
by ncormierdesign | Apr 24, 2023 | Publications
Affera's technology news and other announcements.
Affera develops medical technology for treating cardiac arrhythmia.
The following policy outlines how Affera, Inc. collects and uses information about visitors to this website.
Medtronic secures FDA approval for its **Affera™ Mapping and Ablation System** and **Sphere-9™ Catheter**, a first-of-its-kind all-in-one device combining high-definition (HD) mapping with dual-energy ablation (pulsed field and radiofrequency). The system is designed to address complex arrhythmias, offering electrophysiologists an integrated solution for improved procedural precision and safety. Early adoption reflects strong anticipation from specialists in the field.
Oct 2024Medtronic NewsNews article
Medtronic secures CE Mark approval for its **Affera™ Mapping and Ablation System**, designed to treat atrial arrhythmias. The system integrates the **Sphere-9™ Catheter**, featuring pulsed field ablation, radiofrequency, and high-density mapping, alongside the **DUBLIN** mapping and navigation platform. This marks the first all-in-one solution of its kind for cardiac arrhythmia treatment.
Mar 2023Medtronic NewsNews article
Medtronic finishes enrolling participants in the **SPHERE Per-AF** trial, assessing its **Sphere-9 pulsed-field ablation catheter** paired with the **Affera mapping system** for treating atrial fibrillation. The study evaluates safety and effectiveness in a pivotal phase. The catheter represents a novel approach to cardiac ablation, aiming to improve outcomes for patients with irregular heart rhythms.
Dec 2022Medtronic NewsNews article
Medtronic acquires Affera to expand its cardiac ablation solutions. The deal integrates Affera’s mapping and navigation platform with Medtronic’s diagnostic and therapeutic tools, targeting a wider range of arrhythmia treatments. The combined system aims to enhance precision in cardiac procedures.
Aug 2022Medtronic NewsNews article